Empowering Blue Zones
Empowering Blue Zones
ResoHealth is a Dubai-based healthcare innovation company established under Peking University Resources Holdings Company Limited (PKURH), a Hong Kong-listed company (Stock Code: 00618).
ResoHealth operates Resohealth.Life , a platform aggregating wellness and preventive health offerings with outcome driven approach. It also provides its customers with LetsGo, an AI-powered digital health record and companion designed to provide integrated, data-driven health management solutions. Built on the preventive care philosophy of the 400-year-old Chinese brand Tong Ren Tang, LetsGo combines traditional medical wisdom with modern AI technologies to address global health challenges at scale.
The platform focuses on four key pillars:
• AI-powered health screening
• Personalized intervention and coaching
• Insurance optimization and cost savings
• Health data management and ecosystem integration
ResoHealth is committed to building a scalable and ethical preventive health ecosystem across key emerging markets, including the United Arab Emirates (UAE), East Africa, India, and Southeast Asia.
Jason Wong is the Chairman of Peking University Resources (Holdings) Limited (stock code: 00618.HK). With over 20 years of experience in asset management, corporate restructuring, and new business development, he has successfully structured debt and equity deals exceeding US$100 million, specializing in capital structuring, strategic investments, and loan syndication. He holds a Bachelor’s degree in Accounting and Commercial Law from Victoria University of Wellington, an Executive MBA jointly awarded by The University of Hong Kong and Peking University, and is currently pursuing a Doctor of Business Administration (DBA) in Emerging Technologies with a concentration in Generative AI from Golden Gate University, USA. In 2021, Jason led the acquisition and restructuring of 00618.HK, reviving the company through targeted financial engineering. In 2024, he is spearheading its strategic pivot into the AI healthcare industry, driving innovation and long-term value creation across emerging sectors.
Prof Richard Siow is a graduate of King’s College London (BSc, PhD). He is Director of Ageing Research at King’s (ARK), a multidisciplinary consortium for healthy ageing, longevity and preventive medicine research. Prof Siow also holds a Visiting Professorship in the Medical Sciences Division, University of Oxford, and is Secretary General of the European Society for Preventive Medicine. He is Editor-in-Chief of Longevity (Taylor & Francis) and a member of the International Advisory Board of The Lancet Healthy Longevity.
Dr. Henry Loh is a dermatologist who established a successful chain of dermatology clinics in Singapore, listed on the Stock Exchange of Hong Kong Limited in 2017. He is a serial investor in medical technology and biotechnology ventures, with notable investments in ManaDr (Singapore), which was listed on NASDAQ in 2023. Dr. Loh believes AI will transform healthcare from a labor-intensive service model into a scalable, data-driven product ecosystem, with subscription-based preventive care as the future of modern medicine.
Dr. Vasanthan Metupalle is a Singaporean healthcare entrepreneur with over 16 years of leadership across Asia, the Middle East, and Africa. He co-founded MyDoc, the first telehealth platform in Asia in 2012, and was awarded the Public Service Medal by Singapore’s Prime Minister’s Office in 2023 for his contribution during COVID-19. He currently operates a multinational healthcare consulting platform supporting digital transformation and cross-border medtech growth, based in Dubai.